24/04/24 -"Sales and EBITDA below consensus (excluding EUR 9mn valuation effects). 2024 EBITDA guidance might trigger no meaningful change of estimates"
24/04/24 -"Sales and EBITDA below consensus (excluding EUR 9mn valuation effects). 2024 EBITDA guidance might trigger no meaningful change of estimates"
AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.
Corporate broking | NO |
Trading in corporate shares | NO |
Analyst ownership | NO |
Advising of corporate (strategy, marketing, debt, etc) | NO |
Research paid for by corporate | NO |
Provision of corporate access paid for by corporate | NO |
Link between and a banking entity | NO |
Brokerage activity at AlphaValue | NO |